Drug shortages

Dextrose Monohydrate 5% Injection

Baxter Healthcare · Available

Current0338-0017-31Endocrinology/Metabolism +3
Open FDA's page for this record
Update type
Reverified
Initial posting date
02/14/2022
Package NDC
0338-0017-31
Generic name
Dextrose Monohydrate 5% Injection
Contact info
888-229-0001
Availability
Available
Update date
09/17/2026
Dosage form
Injection
Presentation
Dextrose 5% In Plastic Container, Injection, 50 g/1000 mL (NDC 0338-0017-31)
Company name
Baxter Healthcare
Status
Current
Therapeutic category
Endocrinology/Metabolism, Gastroenterology, Other, Pediatric
Harmonized identifiers (openFDA)
Application number
NDA016673
Brand name
DEXTROSE
Generic name
DEXTROSE MONOHYDRATE
Manufacturer name
Baxter Healthcare Corporation
Product NDC
0338-0017, 0338-0023
Product type
HUMAN PRESCRIPTION DRUG
Route
INTRAVENOUS
Substance name
DEXTROSE MONOHYDRATE
RxCUI
1795477, 1795480, 1795481, 1795607, 1795609, 1795610, 1795612, 1795616, 1795618
SPL ID
9c644eb4-5844-415a-8c01-4459d98af222
SPL set ID
3bb406a9-f5cb-403a-b1bb-5c4facbea3d5
Package NDC
0338-0017-10, 0338-0017-41, 0338-0017-11, 0338-0017-31, 0338-0017-48, 0338-0017-18, 0338-0017-38, 0338-0017-02, 0338-0017-03, 0338-0017-04, 0338-0023-02, 0338-0023-03, 0338-0023-04
UNII
LX22YL083G
Wholesale access for licensed clinicians.

Free to join: your NPI is checked against the federal registry at signup, then wholesale pricing and the professional shelves open.

Data from openFDA, FDA's public API. FDA says not to rely on it to make decisions about medical care and to treat every result as unvalidated; confirm against FDA's own record and the product labeling. Not medical or legal advice.